Telemedicine Contraceptive Counselling (TECC) Versus Standard Care
Launched by KAROLINSKA INSTITUTET · Nov 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to provide contraceptive counseling through telemedicine, which means using technology like smartphones to give advice and support remotely. The goal is to help women access and use contraception after having an abortion more easily. The trial will take place in South Africa and Kenya, and researchers are comparing this telemedicine approach to standard in-person counseling to see which is more effective.
To be eligible for the study, participants need to be at least 18 years old, seeking either a surgical or medical abortion, and able to communicate in spoken and written English. They should also have a private smartphone to participate. If you join this study, you can expect to receive guidance on contraception through a telemedicine service, which could be a convenient option for you. The trial is currently recruiting participants, and it’s a great opportunity to contribute to important research that could improve contraceptive access for women in the future.
Gender
FEMALE
Eligibility criteria
- • Seeking either surgical or medical abortion
- • ≥ 18 years of age
- • Able to communicate and understand spoken and written English
- • With private access to a smart phone
- • Willing to participate in the study procedures
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cape Town, , South Africa
Cape Town, , South Africa
Patients applied
Trial Officials
Margit Endler, PhD
Principal Investigator
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported